Skip to content

NOICE vs. Nothing | Thermode

NOICE vs. Nothing | Thermode: A Prospective, Randomized, Crossover Study

Status
Withdrawn
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06919497
Enrollment
0
Registered
2025-04-09
Start date
2025-11-01
Completion date
2026-09-30
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spatial Audio Stimulation

Keywords

Thermal Sensory Analyzer (TSA-II), Peltier-Based Contact Thermode

Brief summary

The purpose of this study is to test whether the non-visual immersive technologies, which uses spatial audio simulation, can help people better tolerate heat pain. As a proof-of-concept study, study team will use the NOICE device. This research is not studying the NOICE device specifically and the device is not a medical device.

Detailed description

This study addresses the research gap in understanding how spatial audio impacts pain perception, specifically heat pain, in clinical settings. It is important to explore this because spatial audio may serve as a non-pharmaceutical, immersive alternative to traditional visual-based distraction methods like virtual reality. The investigators hypothesize that participants using the spatial audio simulation device will report an increased heat pain threshold compared to not using the device. This knowledge could improve information on the perception of pain for participant who prefer not to use VR headsets.

Interventions

BEHAVIORALSpatial audio stimulation

Study RA will affix the thermode to the dorsum of the participant's dominant or non-dominant hand. Participants will undergo heat-pain-inducing thermode exposure. The intervention will be randomized to receive spatial audio stimulation or not for the first HPT trial, then crossed over to the other study condition for the second HPT trial. Participants will be randomized to expose their dominant or non-dominant hand first. Between each levels test, the thermode will be moved to the other hand (ex: VR: DH, NDH, DH; Nothing: NDH, DH, NDH). There will be a 30 second break between each levels test and a five-minute washout period between each intervention.

BEHAVIORALNo spatial audio stimulation

Study RA will affix the thermode to the dorsum of the participant's dominant or non-dominant hand. Participants will undergo heat-pain-inducing thermode exposure. The intervention will be randomized to receive spatial audio stimulation or not for the first HPT trial, then crossed over to the other study condition for the second HPT trial. Participants will be randomized to expose their dominant or non-dominant hand first. Between each levels test, the thermode will be moved to the other hand (ex: VR: DH, NDH, DH; Nothing: NDH, DH, NDH). There will be a 30 second break between each levels test and a five-minute washout period between each intervention.

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* Ages 18 years and older * English-speaking * Intact hearing * No self-reported or clinically diagnosed acute or chronic medical conditions that affect safe participation

Exclusion criteria

* Use chronotropic heart medications * Use pain medications * Current hearing loss * Currently taking beta blockers, or opioids or other prescription pain medications * History of chronic pain or acute pain syndromes * Current hearing loss

Design outcomes

Primary

MeasureTime frameDescription
Change in heat pain thresholdDuration of intervention, approximately 15 minutesHeat pain threshold measured by the TSA Air II device. Temperature ranges from 32 degrees C to 44 degrees C, with higher temperatures indicating a higher heat pain threshold.

Secondary

MeasureTime frameDescription
Change in heat pain sensitivity (HPS)immediately after interventionTo evaluate heat pain sensitivity(HPS), participants will complete the Numerical Rating Pain Scale (NRPS) immediately following each trial, where they rank pain sensitivity on an ordinal scale from 0 = no pain to 10 = worst pain possible under both treatment conditions.
Anxiety Levelimmediately after interventionparticipants will complete the Visual Analog Scale for Measuring Anxiety (VAS-A) immediately following each group of levels tests, where they will rank anxiety scores on a sliding scale from 0 = No anxiety/fear to 100 = Worst possible anxiety/fear
ISO Ergonomic scaleimmediately after interventionThe scale has 6 items. Scores ranges from 1-5 (1 = strongly disagree and 5 = strongly agree)
System Usability Scale (SUS) Scoreimmediately after interventionThe scale has 10 items. Scores ranges from 1-5 (1 = strongly disagree and 5 = strongly agree)
Device satisfactionimmediately after interventionTo evaluate the overall impact of device satisfaction of the spatial audio stimulation device, participants will complete the Patient Technology Satisfaction Survey. Participants will rank each factor on a Likert scale from 1 = not at all to 5 = completely.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 19, 2026